Kostas Vavitsas, Author at Labiotech.eu

About

Kostas Vavitsas, PhD, is a Senior Research Associate at the University of Athens, Greece, and a freelance writer on biotech and synthetic biology topics.

Articles by Kostas Vavitsas

News and Trends 17 Jul 2020

Two UK Startups Raise Seed Funding to Revolutionize Cancer Treatment

Unfazed by the financial turmoil caused by the Covid-19 pandemic, the Edinburgh-based firm Macomics and University of Cambridge spinout Spirea have each closed seed rounds this week to finance the development of novel cancer immunotherapies and more precise forms of chemotherapy. Macomics bagged €3.5M (£3.2M) in seed funding from the transatlantic VC firm Epidarex Capital […]

July 17, 2020 - 3 minutesmins - By Kostas Vavitsas

varmx blood thinners clot eartern brown snake

News and Trends 14 Jul 2020

€32M Series B to Fund Bleeding Medication Inspired by Snake Venom

The Dutch biotech VarmX will use the proceedings of a €32M Series B to take a blood clotting protein drug into clinical trials by 2021, as well as strengthening its manufacturing and R&D capabilities. More than 10 million patients in the US and Europe at risk of blood clots and strokes receive blood thinners that […]

July 14, 2020 - 2 minutesmins - By Kostas Vavitsas

News and Trends 8 Jul 2020

Osivax Raises €32M to Develop Universal Coronavirus and Influenza Vaccines

Osivax, a Lyon-based biotechnology company, secured €17.5M from the European Innovation Council and €15.1M from Bpifrance. The funding will be used to develop vaccines that protect from all current – and even future – flu and coronavirus outbreaks. Most current vaccines have a specific target protein they work against. They train the immune system to […]

July 8, 2020 - 3 minutesmins - By Kostas Vavitsas

sonoran desert toad psychedelic beckley psytech

News and Trends 1 Jul 2020

UK Startup Bags €3M to Develop Psychedelic Medicines for Mental Health

A €3.3M (£3M) Series A round raised by the Oxford-based biomedicine company Beckley Psytech will allow the company to study the use of a psychedelic compound for the treatment of mental health disorders and neuropsychiatric disease. The investors include the UK VC firms Mediqventures and Jamjar Investments, which was set up by Richard Reed, co-founder […]

July 1, 2020 - 3 minutesmins - By Kostas Vavitsas

glutamate umami novozymes alternative meat

News and Trends 25 Jun 2020

Novozymes Launches Eco-Friendly Umami Flavoring Made with Enzymes

As consumers demand more and better plant-based alternatives to meat, the Danish biotech company Novozymes has released an environmentally friendly way of producing umami flavorings using enzymes rather than chemical methods. Umami is the savory taste often associated with cooked meat. This flavor is triggered by an amino acid called glutamic acid, which is often […]

June 25, 2020 - 2 minutesmins - By Kostas Vavitsas

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us